Detalhe da pesquisa
1.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Lancet;
403(10442): 2416-2425, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38763153
2.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Lancet;
403(10442): 2405-2415, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38763154
3.
Considerations for using potential surrogate endpoints in cancer screening trials.
Lancet Oncol;
25(5): e183-e192, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38697164
4.
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
N Engl J Med;
384(10): 905-914, 2021 03 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33356051
5.
Multi-arm multi-stage (MAMS) randomised selection designs: impact of treatment selection rules on the operating characteristics.
BMC Med Res Methodol;
24(1): 124, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38831421
6.
Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson's disease.
Brain;
146(7): 2717-2722, 2023 07 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36856727
7.
When should factorial designs be used for late-phase randomised controlled trials?
Clin Trials;
21(2): 162-170, 2024 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37904490
8.
REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatment.
Lancet Oncol;
24(5): e219-e227, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37142383
9.
Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial.
Lancet Oncol;
24(9): 1018-1028, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37657461
10.
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials.
Lancet Oncol;
24(7): 783-797, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37414011
11.
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Lancet;
399(10323): 447-460, 2022 01 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34953525
12.
Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Gynecol Oncol;
179: 123-130, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37980767
13.
Treatment selection in multi-arm multi-stage designs: With application to a postpartum haemorrhage trial.
Clin Trials;
20(1): 71-80, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36647713
14.
A comparison of different population-level summary measures for randomised trials with time-to-event outcomes, with a focus on non-inferiority trials.
Clin Trials;
20(6): 594-602, 2023 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37337728
15.
Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery.
Am J Respir Crit Care Med;
206(6): 730-739, 2022 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35580040
16.
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.
Ann Intern Med;
175(2): 234-243, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34928698
17.
artbin: Extended sample size for randomized trials with binary outcomes.
Stata J;
23(1): 24-52, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37461744
18.
artcat: Sample-size calculation for an ordered categorical outcome.
Stata J;
23(1): 3-23, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37155554
19.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol;
23(7): 919-930, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35690073
20.
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
PLoS Med;
19(6): e1003998, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35671327